Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Equillium (EQ) has a market cap of $16.538 million USD. According to our data, Equillium is ranked No.8627 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $16.54 M |
-37.76%
|
| Dec 31, 2024 | $26.57 M |
4.17%
|
| Dec 29, 2023 | $25.51 M |
-32.08%
|
| Dec 30, 2022 | $37.56 M |
-71.88%
|
| Dec 31, 2021 | $0.13 B |
-29.53%
|
| Dec 31, 2020 | $0.19 B |
58.28%
|
| Dec 31, 2019 | $0.12 B |
-58.58%
|
| Dec 31, 2018 | $0.29 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Incyte
INCY
|
$11.31 B |
0.000 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.33 B |
50.456 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
USA
|
 Moderna
MRNA
|
$10.02 B |
-0.124 B
|
USA
|
 Novavax
NVAX
|
$1.03 B |
0.000 M
|
USA
|
 Vir Biotechnology
VIR
|
$0.77 B |
-0.000 M
|
USA
|
 bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.22 B |
-0.124 B
|
Switzerland
|
| Market Cap | = | EQ Stock Price | * | EQ Shares Outstanding |
| = | $0.46 | * | 35.72 M | |
| = | $16.54 M |